Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Status:
Completed
Trial end date:
2016-10-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the comparative single-dose pharmacokinetics
(bioequivalence) of lidocaine patch 1.8% (investigational product) versus Lidoderm®
(lidocaine patch 5%,reference product).